FIELD: medicine.
SUBSTANCE: invention refers to treatment and/or prevention of skin toxicity caused by a targeted therapy. Method comprises administering to patient a pharmaceutical composition for local application containing 0.1 to 0.3 wt % berberine, and said targeted therapy is selected from a group consisting of MEK inhibitors, HER2 inhibitors and mTOR inhibitors.
EFFECT: invention provides a wider range of products, namely new effective methods of treating various skin diseases, accompanied by face redness, as well as skin toxicity caused by the targeted therapy.
6 cl, 2 tbl, 4 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING WATER-SOLUBLE PHARMACEUTICAL COMPOSITION BASED ON BERBERINE | 2023 |
|
RU2814497C1 |
| COMPOSITIONS CONTAINING BERBERINE OR ANALOGS THEREOF FOR TREATING ROSACEA OR RED FACE RELATED SKIN DISORDERS | 2014 |
|
RU2671492C2 |
| COMPOSITIONS CONTAINING BERBERINE OR ITS ANALOGUES FOR TREATING SKIN DISEASES RELATED TO ROSACEA OR BLUSH | 2010 |
|
RU2533458C2 |
| METHOD OF DERMATOLOGICAL REACTIONS CORRECTION IN ONCOLOGICAL PATIENTS WHEN USING THERAPY WITH EGFR INHIBITORS | 2018 |
|
RU2689993C1 |
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| THERAPEUTIC USE OF OXIDATIVE HYPOTONIC ACID SOLUTIONS | 2020 |
|
RU2822544C2 |
| USING ALLOPURINOL FOR TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME | 2010 |
|
RU2543325C2 |
| COMPOSITION OF DERMAL MEDICATION FOR EXTERNAL APPLICATION | 2010 |
|
RU2572694C2 |
| ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2014 |
|
RU2698796C2 |
| METHOD FOR TREATING DISEASES AND CONDITIONS OF THE EYE | 2012 |
|
RU2667645C1 |
